In a study by Bostancı et al. [28], granulocyte colony-stimulating factor (G-CSF), a glycoprotein commonly used to treat neutropenia by mobilizing bone marrow-derived hematopoietic cells into peripheral blood, was used in an experimental model of ischemia-reperfusion injury. The gene discussed is CSF3; the disease is Decreased total neutrophil count.